Luis Alfonso Pérez-González

Dr. Luis Alfonso Pérez-González

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Montserrat Fernández-GuarinoMontserrat Fernández-Guarino
Montserrat Fernández-Guarino
Stefano BacciStefano Bacci
Stefano Bacci
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
MMMARIANO BERMEJO MARTÍNEZ
MARIANO BERMEJO MARTÍNEZ
ACAlmudena Cecilia-Matilla
Almudena Cecilia-Matilla
MHMaria Luisa Luisa Hernandez-Bule
Maria Luisa Luisa Hernandez-Bule
Wound healing (WH) is a complex multistep process in which a failure could lead to a chronic wound (CW). CW is a major health problem and includes leg venous ulcers, diabetic foot ulcers, and pressure ulcers. CW is difficult to treat and affects vulnerable and pluripathological patients. On the other hand, excessive scarring leads to keloids and hypertrophic scars causing disfiguration and sometimes itchiness and pain. Treatment of WH includes the cleaning and careful handling of injured tissue, early treatment and prevention of infection, and promotion of healing. Treatment of underlying conditions and the use of special dressings promote healing. The patient at risk and risk areas should avoid injury as much as possible. This review aims to summarize the role of physical therapies as complementary treatments in WH and scarring. The article proposes a translational view, opening the opportunity to develop these therapies in an optimal way in clinical management, as many of them are emerging. The role of laser, photobiomodulation, photodynamic therapy, electrical stimulation, ultrasound therapy, and others are highlighted in a practical and comprehensive approach.
1

10 July 2025 in Cosmetics
Verified
Journal Article
Open access
PDF file
JNJorge Naharro-Rodriguez
Jorge Naharro-Rodriguez
Stefano BacciStefano Bacci
Stefano Bacci
MHMaria Luisa Hernandez-Bule
Maria Luisa Hernandez-Bule
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
Montserrat Fernández-GuarinoMontserrat Fernández-Guarino
Montserrat Fernández-Guarino
Skin aging is a multifactorial process driven by both intrinsic mechanisms—such as telomere shortening, oxidative stress, hormonal decline, and impaired autophagy—and extrinsic influences including ultraviolet radiation, pollution, smoking, and diet. Together, these factors lead to the structural and functional deterioration of the skin, manifesting as wrinkles, pigmentation disorders, thinning, and reduced elasticity. This review provides an integrative overview of the biological, molecular, and clinical dimensions of skin aging, emphasizing the interplay between inflammation, extracellular matrix degradation, and senescence-associated signaling pathways. We examine histopathological hallmarks and molecular markers and discuss the influence of genetic and ethnic variations on aging phenotypes. Current therapeutic strategies are explored, ranging from topical agents (e.g., retinoids, antioxidants, niacinamide) to procedural interventions such as lasers, intense pulsed light, photodynamic therapy, microneedling, and injectable biostimulators. Special attention is given to emerging approaches such as microneedle delivery systems, with mention of exosome-based therapies. The review underscores the importance of personalized anti-aging regimens based on biological age, phototype, and lifestyle factors. As the field advances, integrating mechanistic insights with individualized treatment selection will be key to optimizing skin rejuvenation and preserving long-term dermal health.

2 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SLSiddhi Bianca Camila Lama
Siddhi Bianca Camila Lama
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
MKMehmet A. Kosoglu
Mehmet A. Kosoglu
RDRobert Dennis
Robert Dennis
DODaniel Ortega-Quijano
Daniel Ortega-Quijano
Androgenetic alopecia, the most common cause of hair loss affecting both men and women, is typically treated using pharmaceutical options, such as minoxidil and finasteride. While these medications work for many individuals, they are not suitable options for all. To date, the only non-pharmaceutical option that the United States Food and Drug Administration has cleared as a treatment for androgenetic alopecia is low-level laser therapy (LLLT). Numerous clinical trials utilizing LLLT devices of various types are available. However, a myriad of other physical treatments for this form of hair loss have been reported in the literature. This review evaluated the effectiveness of microneedling, pulsed electromagnetic field (PEMF) therapy, low-level laser therapy (LLLT), fractional laser therapy, and nonablative laser therapy for the treatment of androgenetic alopecia (AGA). It also explores the potential of multimodal treatments combining these physical therapies. The majority of evidence in the literature supports LLLT as a physical therapy for androgenetic alopecia. However, other physical treatments, such as nonablative laser treatments, and multimodal approaches, such as PEMF-LLLT, seem to have the potential to be equally or more promising and merit further exploration.

Verified
Journal Article
Open access
PDF file
MHMaria Luisa Luisa Hernandez-Bule
Maria Luisa Luisa Hernandez-Bule
ETElena Toledano-Macías
Elena Toledano-Macías
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
MMMaría Antonia Martínez
María Antonia Martínez
Montserrat Fernández-GuarinoMontserrat Fernández-Guarino
Montserrat Fernández-Guarino
Hypertrophic scars and keloids are two different manifestations of excessive dermal fibrosis and are caused by an alteration in the normal wound-healing process. Treatment with radiofrequency (RF)-based therapies has proven to be useful in reducing hypertrophic scars. In this study, the effect of one of these radiofrequency therapies, Capacitive Resistive Electrical Transfer Therapy (CRET) on biomarkers of skin fibrosis was investigated. For this, in cultures of human myofibroblasts treated with CRET therapy or sham-treated, proliferation (XTT Assay), apoptosis (TUNEL Assay), and cell migration (Wound Closure Assay) were analyzed. Furthermore, in these cultures the expression and/or localization of extracellular matrix proteins such as α-SMA, Col I, Col III (immunofluorescence), metalloproteinases MMP1 and MMP9, MAP kinase ERK1/2, and the transcription factor NFκB were also investigated (immunoblot). The results have revealed that CRET decreases the expression of extracellular matrix proteins, modifies the expression of the metalloproteinase MMP9, and reduces the activation of NFκB with respect to controls, suggesting that this therapy could be useful for the treatment of fibrotic pathologies.

28 June 2024 in Life
Verified
Journal Article
Open access
PDF file
EGEmilio Garcia-Mouronte
Emilio Garcia-Mouronte
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
JNJorge Naharro-Rodriguez
Jorge Naharro-Rodriguez
Montserrat Fernández-GuarinoMontserrat Fernández-Guarino
Montserrat Fernández-Guarino
The detrimental effects of ultraviolet radiation (UVR) on human skin are well-documented, encompassing DNA damage, oxidative stress, and an increased risk of carcinogenesis. Conventional photoprotective measures predominantly rely on filters, which scatter or absorb UV radiation, yet fail to address the cellular damage incurred post-exposure. To fill this gap, antioxidant molecules and DNA–repair enzymes have been extensively researched, offering a paradigm shift towards active photoprotection capable of both preventing and reversing UV–induced damage. In the current review, we focused on “active photoprotection”, assessing the state-of-the-art, latest advancements and scientific data from clinical trials and in vivo models concerning the use of DNA-repair enzymes and naturally occurring antioxidant molecules.

Verified
Journal Article
Open access
PDF file
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
EGEmilio Garcia-Mouronte
Emilio Garcia-Mouronte
JNJorge Naharro-Rodriguez
Jorge Naharro-Rodriguez
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
Montserrat Fernández-GuarinoMontserrat Fernández-Guarino
Montserrat Fernández-Guarino
Photodynamic therapy (PDT) has become a widely used modality for treating actinic keratosis (AK) and non-melanoma skin cancers (NMSC), as well as other inflammatory or infectious diseases. Despite its efficacy, limitations such as incomplete responses and pain have motivated the exploration of protocol enhancements. This review examines the clinical and biological rationale for light fractionation—dividing the total light dose into two separate exposures with a dark interval—as a strategy to improve PDT outcomes. We reviewed preclinical and clinical studies evaluating fractionated illumination using 5-aminolevulinic acid (ALA) or methyl aminolevulinate (MAL). The findings consistently demonstrate superior efficacy of fractionated schemes, particularly with ALA, showing higher complete response rates in AK, superficial basal cell carcinoma (sBCC), and Bowen’s disease (BD), and improved long-term tumor control compared to single illumination. The better outcomes are attributed to increased reactive oxygen species (ROS) generation following tissue reoxygenation during the dark interval and greater susceptibility of partially damaged cells to subsequent illumination. Fractionated PDT also shows a favorable safety and cosmetic profile. These results support considering light fractionation protocols as a standard approach for optimizing PDT efficacy in dermatologic oncology, particularly in lesions with limited depth and high recurrence risk.